Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
      Description

      The purpose of this study was to demonstrate superiority of treatment with avelumab plus best supportive care (BSC) versus physician's choice (chosen from a pre-specified list of therapeutic options) plus BSC.

      Conditions
      Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaGastric Cancer Third Line
      Talk to us